News

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.
Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.
The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...
Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...
The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...
The Slovak government halted purchases of COVID-19 vaccines on Wednesday pending a review of their safety by the Slovak ...
One in five Irish people said they would not take a traditional vaccine, a worldwide research project found. A further one in ...
March 5, 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine ...